Vanda Pharmaceuticals Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 51.7M | 57.2M | 56.3M | 52.6M | 50.0M | 53.2M | 47.7M | 50.5M |
| Cost of Goods Sold | 5.1M | 3.8M | 3.0M | 4.5M | 3.5M | 2.6M | 2.6M | 4.5M |
| Gross Profit | 46.6M | 53.4M | 53.3M | 48.1M | 46.5M | 50.6M | 45.1M | 46.0M |
| R&D Expenses | 28.4M | 29.0M | 22.6M | 22.0M | 35.7M | 19.8M | 16.8M | 16.7M |
| Operating Expenses | 96.8M | 93.7M | 84.6M | 86.6M | 91.1M | 60.9M | 56.1M | 56.1M |
| Operating Income | -50.2M | -40.4M | -31.3M | -38.5M | -44.5M | -10.3M | -11.0M | -10.1M |
| Other Income / Gains | 1.8M | 2.4M | 2.9M | 3.6M | 7.2M | 3.8M | 4.8M | 4.6M |
| Net Income | -48.6M | -141.2M | -22.6M | -27.2M | -29.5M | -4.9M | -5.3M | -4.5M |
| EPS (Diluted) | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.085 | -0.091 | -0.078 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.90 | 0.933 | 0.947 | 0.915 | 0.93 | 0.951 | 0.946 | 0.911 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 37.4M | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 1.9M | 0 | 0 |
| Selling General And Administrative Expenses | 68.4M | 63.0M | 60.3M | 64.6M | 50.1M | 39.3M | 37.6M | 39.5M |
| Other Expenses | 0 | 1.8M | 1.8M | 0 | 5.3M | 1.8M | 1.8M | 0 |
| Cost And Expenses | 101.9M | 97.6M | 87.5M | 91.1M | 94.6M | 63.5M | 58.7M | 60.6M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 3.5M | 5.9M | 2.1M | 2.0M | 980K | 2.0M | 2.0M | 2.0M |
| Ebitda | -44.9M | -32.1M | -26.3M | -32.9M | -31.1M | -4.5M | -4.3M | -3.5M |
| Ebitdaratio | -0.868 | -0.562 | -0.468 | -0.625 | -0.622 | -0.085 | -0.09 | -0.07 |
| Operating Income Ratio | -0.971 | -0.705 | -0.556 | -0.732 | -0.89 | -0.193 | -0.231 | -0.201 |
| Income Before Tax | -48.4M | -38.0M | -28.4M | -34.9M | -37.4M | -6.5M | -6.2M | -5.5M |
| Income Before Tax Ratio | -0.936 | -0.664 | -0.505 | -0.663 | -0.747 | -0.122 | -0.131 | -0.109 |
| Income Tax Expense | 143K | 103.2M | -5.8M | -7.7M | -7.9M | -1.6M | -920K | -998K |
| Net Income Ratio | -0.939 | -2.468 | -0.401 | -0.517 | -0.589 | -0.092 | -0.112 | -0.09 |
| Epsdiluted | -0.82 | -2.39 | -0.38 | -0.46 | -0.50 | -0.085 | -0.091 | -0.078 |
| Weighted Average Shs Out | 59.5M | 59.1M | 58.9M | 59.0M | 58.5M | 58.3M | 58.3M | 58.2M |
| Weighted Average Shs Out Dil | 59.5M | 59.1M | 58.9M | 59.0M | 58.5M | 58.3M | 58.3M | 58.2M |